Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in shares of Tilray Inc (NASDAQ:TLRY) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 1,512 shares of the company’s stock, valued at approximately $70,000.
Other institutional investors have also modified their holdings of the company. Stelac Advisory Services LLC bought a new position in shares of Tilray in the 2nd quarter worth approximately $3,000,000. Traynor Capital Management Inc. purchased a new position in Tilray in the second quarter worth about $347,000. Commerzbank Aktiengesellschaft FI purchased a new position in Tilray in the second quarter worth about $239,000. Commonwealth Equity Services LLC grew its position in Tilray by 47.5% in the second quarter. Commonwealth Equity Services LLC now owns 26,599 shares of the company’s stock worth $1,238,000 after acquiring an additional 8,570 shares in the last quarter. Finally, Exane Derivatives grew its position in Tilray by 1,177.3% in the second quarter. Exane Derivatives now owns 16,720 shares of the company’s stock worth $780,000 after acquiring an additional 15,411 shares in the last quarter. Institutional investors and hedge funds own 5.25% of the company’s stock.
In other Tilray news, Director Christine St.Clare sold 4,000 shares of the company’s stock in a transaction on Thursday, June 20th. The shares were sold at an average price of $50.01, for a total value of $200,040.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 3.40% of the stock is currently owned by corporate insiders.
NASDAQ:TLRY traded down $0.45 during mid-day trading on Friday, hitting $28.56. The company’s stock had a trading volume of 92,478 shares, compared to its average volume of 1,656,908. Tilray Inc has a 1 year low of $28.72 and a 1 year high of $300.00. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.04 and a quick ratio of 1.61. The stock has a market cap of $2.85 billion and a price-to-earnings ratio of -34.85. The business’s fifty day moving average is $41.52 and its two-hundred day moving average is $53.74.
Tilray (NASDAQ:TLRY) last posted its quarterly earnings results on Tuesday, August 13th. The company reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.09). Tilray had a negative net margin of 121.73% and a negative return on equity of 37.64%. The business had revenue of $45.90 million during the quarter, compared to analysts’ expectations of $40.25 million. During the same period in the previous year, the company posted ($0.17) earnings per share. Tilray’s revenue for the quarter was up 373.2% compared to the same quarter last year. Analysts anticipate that Tilray Inc will post -1.05 EPS for the current fiscal year.
Several research firms recently commented on TLRY. LADENBURG THALM/SH SH began coverage on Tilray in a research report on Wednesday, July 17th. They issued a “neutral” rating for the company. Oppenheimer began coverage on Tilray in a research report on Tuesday, June 4th. They issued a “market perform” rating for the company. Alliance Global Partners began coverage on Tilray in a research report on Monday, May 13th. They issued a “neutral” rating and a $50.00 price target for the company. Northland Securities reiterated a “hold” rating on shares of Tilray in a research report on Wednesday, August 14th. Finally, Stifel Nicolaus restated a “hold” rating on shares of Tilray in a research report on Wednesday, August 14th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $67.24.
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Inc (NASDAQ:TLRY).
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.